ZA894096B - Alpha-adrenergic receptor antagonists - Google Patents

Alpha-adrenergic receptor antagonists

Info

Publication number
ZA894096B
ZA894096B ZA894096A ZA894096A ZA894096B ZA 894096 B ZA894096 B ZA 894096B ZA 894096 A ZA894096 A ZA 894096A ZA 894096 A ZA894096 A ZA 894096A ZA 894096 B ZA894096 B ZA 894096B
Authority
ZA
South Africa
Prior art keywords
alpha
receptor antagonists
adrenergic receptor
antagonists
adrenoceptor
Prior art date
Application number
ZA894096A
Other languages
English (en)
Inventor
John Joseph Lafferty
Joseph Lafferty John
Robert Michael Demarinis
Michael Demarinis Robert
Joseph Walter Venslavsky
Walter Venslavsky Joseph
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of ZA894096B publication Critical patent/ZA894096B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
ZA894096A 1988-06-01 1989-05-30 Alpha-adrenergic receptor antagonists ZA894096B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20081688A 1988-06-01 1988-06-01

Publications (1)

Publication Number Publication Date
ZA894096B true ZA894096B (en) 1990-06-27

Family

ID=22743334

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA894096A ZA894096B (en) 1988-06-01 1989-05-30 Alpha-adrenergic receptor antagonists

Country Status (13)

Country Link
EP (1) EP0344982B1 (xx)
JP (1) JPH03504606A (xx)
KR (1) KR900701788A (xx)
CN (1) CN1038099A (xx)
AT (1) ATE114310T1 (xx)
AU (1) AU630100B2 (xx)
CA (1) CA1320485C (xx)
DE (1) DE68919438T2 (xx)
NZ (1) NZ229296A (xx)
PT (1) PT90717B (xx)
WO (1) WO1989012051A1 (xx)
ZA (1) ZA894096B (xx)
ZW (1) ZW6889A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1320486C (en) * 1988-06-01 1993-07-20 John J. Lafferty .alpha. -adrenergic receptor antagonists
CN100391460C (zh) * 2002-06-20 2008-06-04 诺瓦乐医药公司 α-肾上腺素能受体拮抗剂的稳定配方及其用途
EP2824106B1 (en) * 2012-03-06 2016-11-23 Takeda Pharmaceutical Company Limited Tricyclic compound

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795451A (fr) * 1972-02-23 1973-08-16 Pfizer Agents hypoglycemiants aza indoliques tricycliques
US3950343A (en) * 1973-11-06 1976-04-13 Ayerst, Mckenna And Harrison Ltd. Pyrroloisoquinoline derivatives
EP0139584B1 (fr) * 1983-10-17 1988-05-18 Synthelabo Dérivés d'imidazoline, leur préparation et leur application en thérapeutique
DE3525564A1 (de) * 1985-07-15 1987-02-05 Schering Ag Tricyclische verbindungen mit indolstruktur, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
CA1320486C (en) * 1988-06-01 1993-07-20 John J. Lafferty .alpha. -adrenergic receptor antagonists

Also Published As

Publication number Publication date
ATE114310T1 (de) 1994-12-15
AU3770889A (en) 1990-01-05
EP0344982A2 (en) 1989-12-06
CN1038099A (zh) 1989-12-20
AU630100B2 (en) 1992-10-22
NZ229296A (en) 1991-05-28
WO1989012051A1 (en) 1989-12-14
PT90717B (pt) 1994-11-30
DE68919438D1 (de) 1995-01-05
DE68919438T2 (de) 1995-05-04
KR900701788A (ko) 1990-12-04
JPH03504606A (ja) 1991-10-09
ZW6889A1 (en) 1989-08-30
CA1320485C (en) 1993-07-20
EP0344982B1 (en) 1994-11-23
EP0344982A3 (en) 1991-05-15
PT90717A (pt) 1989-12-29

Similar Documents

Publication Publication Date Title
DE69034103D1 (de) Imidazoalkensäure
PL287631A1 (en) Method of obtaining novel substituted derivatives of n-/imidazolil/-alkyl-alamine
ZA894098B (en) Alpha-adrenergic receptor antagonists
ZA894096B (en) Alpha-adrenergic receptor antagonists
ZA894099B (en) Alpha-adrenergic receptor antagonists
EP0344980A3 (en) Alpha-adrenergic receptor antagonists